168 related articles for article (PubMed ID: 31369651)
1. Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
Mizuno H; Yuasa N; Takeuchi E; Miyake H; Nagai H; Yoshioka Y; Miyata K
PLoS One; 2019; 14(8):e0220579. PubMed ID: 31369651
[TBL] [Abstract][Full Text] [Related]
2. The mean corpuscular volume as a prognostic factor for colorectal cancer.
Nagai H; Yuasa N; Takeuchi E; Miyake H; Yoshioka Y; Miyata K
Surg Today; 2018 Feb; 48(2):186-194. PubMed ID: 28795308
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
[TBL] [Abstract][Full Text] [Related]
4. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
5. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
6. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
Lee JW; Baek MJ; Ahn TS; Lee SM
Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):187-194. PubMed ID: 29120905
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of preoperative mean corpuscular volume in colorectal cancer.
Nakamura K; Seishima R; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Jpn J Clin Oncol; 2022 May; 52(6):562-570. PubMed ID: 35253057
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis.
Tan D; Fu Y; Tong W; Li F
Int J Surg; 2018 Jul; 55():128-138. PubMed ID: 29807167
[TBL] [Abstract][Full Text] [Related]
11. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
14. Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients.
Guo D; Han A; Jing W; Chen D; Jin F; Li M; Kong L; Yu J
Future Oncol; 2018 May; 14(12):1187-1196. PubMed ID: 29302993
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
Huang L; Fang J; Wu J; Zhou X; Wei H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.
Koch M; Kienle P; Kastrati D; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Int J Cancer; 2006 Jun; 118(12):3072-7. PubMed ID: 16425256
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
